Drugs / DPSC
last change Dec 2016 re-read 3 minutes ago

DPSC

Cell therapy

Developed for
chronic periodontitis
Investigated by
Songlin Wang

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02523651 Dec 2014 → Dec 2015 chronic periodontitis Songlin Wang Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DPSC ClinicalTrials.gov intervention name — accepted as the source's own label NCT02523651 ↗
Modality Cell therapy “allogeneic human dental pulp stem cell(DPSC)” NCT02523651 ↗
Route Other “injected at the local periodontal defects immediately after periodontal scaling and root planing.” NCT02523651 ↗